IFL regimen
|
WikiDoc Resources for IFL regimen |
|
Articles |
|---|
|
Most recent articles on IFL regimen Most cited articles on IFL regimen |
|
Media |
|
Powerpoint slides on IFL regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on IFL regimen at Clinical Trials.gov Clinical Trials on IFL regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on IFL regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on IFL regimen Discussion groups on IFL regimen Patient Handouts on IFL regimen Directions to Hospitals Treating IFL regimen Risk calculators and risk factors for IFL regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for IFL regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:IFL-Modified Saltz Regimen; IFL-Saltz Regimen; IFL Regimen; Irinotecan-Fluorouracil-Leucovorin Regimen
Overview
IFL regimen refers to a regimen consisting of irinotecan, fluorouracil and leucovorin, all administered as bolus doses, and used for the treatment of advanced stage colorectal cancer.[1]
Regimen
IIrinotecan
FFluorouracil
LLeucovorin
Indications
- Advanced stage colorectal cancer.[2]